HLA profile in paediatric ITP : Comparison with healthy controls and prognostic implications
British Journal of Haematology · 2026-06 · 208 (6) · 2175-2184
DOI: 10.1111/bjh.70483 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Haematology, online erschienen am 29.04.2026. Verfasst von Jesús González de Pablo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Fundación Para la Investigación Biomédica del Hospital I…. Hauptthemen laut MEDLINE: HLA Antigens, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fundación Familia Alonso, Garantía Juvenil.
Abstract (Originalsprache)
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated low platelet counts. Although several studies have explored the relationship between the human leucocyte antigen (HLA) system and ITP, findings have been inconsistent. We compared HLA typing between paediatric ITP patients and healthy controls to assess its role in ITP susceptibility. We also evaluated the association between HLA alleles and clinical outcomes in our paediatric ITP cohort. This retrospective observational study included 135 patients with primary ITP and a control group of 929 healthy individuals. The median age of ITP patients was 5.71 years (Interquartile range 2.71–10.21). The HLA‐DRB1*07 and HLA‐DRB1*13 alleles were more prevalent in healthy controls than in ITP patients, suggesting a potential protective role ( p < 0.05). In contrast, HLA‐A*68, HLA‐B*40 and HLA‐DRB1*14 alleles were associated with an increased risk of ITP ( p < 0.05). Regarding prognosis, HLA‐A*26 allele correlated with lower recovery rates, while HLA‐C*03 allele was associated with a higher recovery likelihood ( p < 0.05). In addition, HLA‐A*02 and HLA‐C*04 alleles and the HLA‐A02 supertype showed a significant association with a higher probability of chronicity ( p < 0.05). Our results highlight the potential role of HLA typing as a diagnostic and prognostic tool for ITP. However, larger studies are required to validate these associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Fundación Para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
- Department of Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.
- Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
- Immunology Unit, Department of Clinical Analysis, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
ORCID-Profile: Luis Marín
Förderung
- Fundación Familia Alonso
- Garantía Juvenil
Zitieren
APA
González de Pablo, J., Molina, Y. L., Vicario, J. L., Moreno Hidalgo, M. Á., de la Cruz, A., Galán, A., Zubicaray, J., López de Hontanar, G., Sanz, A., Marín, L., Verdejo de Antonio, J., Sevilla, J., & Sebastián, E. (2026). HLA profile in paediatric ITP : Comparison with healthy controls and prognostic implications. British Journal of Haematology, 208(6), 2175-2184. https://doi.org/10.1111/bjh.70483
Vancouver
González de Pablo J, Molina YL, Vicario JL, Moreno Hidalgo MÁ, de la Cruz A, Galán A, et al. HLA profile in paediatric ITP : Comparison with healthy controls and prognostic implications. British Journal of Haematology. 2026;208(6):2175-2184. doi:10.1111/bjh.70483
BibTeX
@article{GonzlezdePablo2026,
author = {González de Pablo, Jesús and Molina, Yessenia L and Vicario, José Luis and Moreno Hidalgo, Miguel Ángel and de la Cruz, Ana and Galán, Almudena and Zubicaray, Josune and López de Hontanar, Guzmán and Sanz, Alejandro and Marín, Luis and Verdejo de Antonio, Jorge and Sevilla, Julián and Sebastián, Elena},
title = {HLA profile in paediatric ITP : Comparison with healthy controls and prognostic implications},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {6},
pages = {2175--2184},
doi = {10.1111/bjh.70483}
}
EUVIMED